Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
topic_facet:"Antibodies, Monoclonal, Humanized"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%221474-0338%22+OR+%221744-764X%22&type=ISN&filter%5B%5D=topic_facet%3A%22Antibodies%2C+Monoclonal%2C+Humanized%22
/vufind/Search/Results?lookfor=%221474-0338%22+OR+%221744-764X%22&type=ISN&filter%5B%5D=topic_facet%3A%22Antibodies%2C+Monoclonal%2C+Humanized%22
Search /vufind/Search2/Results?lookfor=%221474-0338%22+OR+%221744-764X%22&type=ISN&filter%5B%5D=topic_facet%3A%22Antibodies%2C+Monoclonal%2C+Humanized%22
PubPharm (92)
1
Dupilumab in real-life settings : a review of adverse events and their pathogenesis
enthalten in:
Expert opinion on drug safety
| 2024
von
Camela, E.
|
Giampetruzzi, A.
|
De Pità, O.
| +2
Wird geladen...
2
Adverse events of guselkumab in the real world : emerging signals to target preventive strategies from the FDA adverse event reporting system
enthalten in:
Expert opinion on drug safety
| 2023
von
Xiang, D.
|
Chen, W.
|
Fu, Z.
| +3
Wird geladen...
3
High risks adverse events associated with trastuzumab emtansine and trastuzumab deruxtecan for the treatment of HER2-positive/mutated malignancies : a pharmacovigilance study based on the FAERS database
enthalten in:
Expert opinion on drug safety
| 2023
von
Ma, P.
|
Tian, H.
|
Shi, Q.
| +4
Wird geladen...
4
An update on the safety of long-term vedolizumab use in inflammatory bowel disease
enthalten in:
Expert opinion on drug safety
| 2023
von
Honap, S.
|
Netter, P.
|
Danese, S.
| +1
Wird geladen...
5
Efficacy and safety of spesolimab for the management of generalized pustular psoriasis : a drug safety evaluation
enthalten in:
Expert opinion on drug safety
| 2023
von
Potestio, L.
|
Camela, E.
|
Cacciapuoti, S.
| +5
Wird geladen...
6
Evaluation of adverse events of bamlanivimab, bamlanivimab/etesevimab used for COVID-19 based on FAERS database
enthalten in:
Expert opinion on drug safety
| 2023
von
Zhao, Y.
|
Wang, H.
|
Zhang, Q.
| +3
Wird geladen...
7
Safety and tolerability of spesolimab in patients with ulcerative colitis
enthalten in:
Expert opinion on drug safety
| 2023
von
Ferrante, M.
|
Irving, P.
|
Selinger, C.
| +9
Wird geladen...
8
Post-marketing safety surveillance of erenumab : new insight from Eudravigilance
enthalten in:
Expert opinion on drug safety
| 2022
von
Liang, D.
|
Sessa, M.
Wird geladen...
9
Safety evaluation of secukinumab in pediatric patients with plaque psoriasis
enthalten in:
Expert opinion on drug safety
| 2022
von
Bardowska, K.
|
Krajewski, P.
|
Tyczyńska, K.
| +1
Wird geladen...
10
Safety and effectiveness of ramucirumab and docetaxel : a single-arm, prospective, multicenter, non-interventional, observational, post-marketing safety study of NSCLC in Japan
enthalten in:
Expert opinion on drug safety
| 2022
von
Chen, Y.
|
Nagaoka, S.
|
Katayose, T.
| +1
Wird geladen...
1
2
3
4
5
6
7
8
9
10
Nächster »
[10]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: Antibodies, Monoclonal, Humanized
Medienart
92
Aufsätze
92
E-Artikel
92
E-Ressourcen
Zeitschriftentitel
92
Expert opinion on drug safety
Thema
Antibodies, Monoclonal, Humanized
92
Journal Article
75
Review
37
Antibodies, Monoclonal
29
safety
14
Antineoplastic Agents
12
Comparative Study
11
EC 2.7.10.1
9
DPT0O3T46P
9
pembrolizumab
8
P188ANX8CK
8
Research Support, Non-U.S. Gov't
8
Trastuzumab
7
Angiogenesis Inhibitors
7
Antirheumatic Agents
7
monoclonal antibody
6
2S9ZZM9Q9V
6
Adalimumab
6
Bevacizumab
6
FYS6T7F842
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
31
2020-
52
2010-2019
9
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
92
Englisch
Haven't found what you're looking for?
Wird geladen...